Scout | Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P30 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P30 Clinical Trial Optional)

This grant opportunity invites applications from currently funded NCI P30 centers to expand their original research or speed up their progress by using a new technique or tool developed through the NCI IMAT program. The goal is to encourage the use and validation of emerging technologies in cancer research. This is aimed at promoting collaboration and innovation in developing tools and methods…

Source

Agency: National Institutes of Health

Program: SBIR

Award

Award Ceiling: $150,000

Funding Amount: $150,000

Dates

Opportunity Released: November 28, 2023

Open for Submission: November 28, 2023

Submission Deadline: October 1, 2024

Application Window Closes: October 1, 2024

Keywords

Cancer Research

Innovative Technologies

NCI P30 Centers

Molecular Analysis

Interdisciplinary Collaboration

Scientific Discovery

Technical Approach

Emerging Technologies

Grant Funding

Research Tools.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers